ArticleHeart rhythm O22026
Atrial fibrillation detection in endurance athletes vs non-athletes: Positive predictive value and burden estimation using implantable cardiac monitors.
Article in Heart rhythm O2, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Implantable cardiac monitors (ICMs) enable continuous arrhythmia detection and quantification of atrial fibrillation (AF) burden. However, the influence of an athletic lifestyle on the positive predictive value (PPV) of ICM-detected AF episodes, and the accuracy of automated AF burden estimation, remain uncertain. Objective: This study aimed to compare the PPV of ICM-detected AF episodes between athletes and non-athletes with known AF, and to evaluate the accuracy of automatic AF burden estimation. Methods: During a 4-week pre-randomization phase of 2 randomized trials, 3041 AF episodes lasting ≥30 seconds were detected by ICMs in 32 endurance athletes and 159 non-athletes with non-permanent AF, totaling 4202 monitored days. All episodes were manually adjudicated to determine true AF. Results: The patient-averaged PPV was 0.59 (95% confidence interval [CI] 0.42-0.74) for athletes and 0.51 (95% CI 0.45-0.58) for non-athletes ( Conclusion: The PPV of ICM-detected AF episodes is similar in athletes and non-athletes. Longer AF episode duration enhances accuracy, and excluding short episodes improves automated AF burden estimation. ICMs may serve as good alternatives for AF monitoring also in athletic subpopulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.